DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Virtual Event

2022 年 10 月 06 日 4:00 下午 - 2022 年 10 月 07 日 11:50 下午

(US Eastern Standard Time)

Horsham, PA 19044

Advancing Diversity, Equity, and Inclusion Across Life Sciences R&D Meeting

Turn insights into action with meaningful exchange across life sciences research and development (R&D) fields.

Session 2: Changing Organizational Culture to Embrace Diversity, Equity, and Inclusion (Part 1)

Session Chair(s)

Kevin  Freiert, MBA

Kevin Freiert, MBA

Owner and Chief Executive Officer

Salem Oaks® Consulting, United States

Alissa  Goodale, DrMed

Alissa Goodale, DrMed

Regulatory Executive Director

Genentech, A Member of the Roche Group, United States

This is part one of two sessions focused on organizational culture change. This session will focus on why changing organizational culture to embrace diversity, equity, and inclusion is an important component of enabling the success of DEI efforts more broadly across multiple areas of R&D. It will also focus on what is needed to affect such a culture change, how change agents can help and how organizational change may be measured.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Formulate a rationale for culture change to support DEI in their organization
  • Distinguish between true culture change (heart & mind) and mandatory processes (compliance)
  • Recognize the importance of selecting and developing change agents to effectively implement culture change

Speaker(s)

Dyan  Bryson

Speaker

Dyan Bryson

TOTAL Diversity Clinical Trial Management, United States

VP, Diversity Services

Trishna  Bharadia

Panelist

Trishna Bharadia

The Spark Global, United Kingdom

Patient Advocate, International Speaker, Writer, Advisor and Content Reviewer

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。